FDA approves new treatment for adults with mantle cell lymphoma - FDA Press Releases

The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.

from Food and Drug Administration--Press Releases http://ift.tt/2hskSiS
via IFTTT